Funder: Pfizer Inc.
Due Dates: April 30, 2026 (Submission deadline, full application)
Funding Amounts: Individual project awards: $50,000–$100,000 USD; Total program budget approx. $700,000 USD; Max project length: 1.5 years
Summary: Supports quality improvement initiatives to enhance atopic dermatitis care and standardize best practices at local healthcare levels in Mainland China.
Key Information: Applications must be submitted by organizations (not individuals) legally able to receive funding from Pfizer Investment Co., Ltd.